Glaxosmithkline Share News (GSK)

Glaxo Says FDA Approves Promacta SNDA In Aplastic Anaemia Patients

UK MIDDAY BRIEFING: Antofagasta And Petrofac Slump Despite Confidence

TOP NEWS: UK Mortgage Approvals Decline Unexpectedly In July

UK BROKER RATINGS: Numis Raises Greene King To Buy From Add

Glaxo's Viiv Healthcare granted FDA approval for HIV tablet

ViiV Healthcare, the specialist HIV company set up by GlaxoSmithKline and Pfizer, has received approval from the Food and Drug Administration (FDA) for Triumeq, its tablet form treatment of the HIV-1 infection. The treatment offers people a single-pill regimen containing dolutegravir, which was its

Tuesday tips round-up: Royal Dutch Shell, Hyder Consulting, GSK

There is a lot to be said for value-based investment strategies as the year-to-date performance of The Daily Telegraph Questor column's six picks for 2014 show. They have held up despite market turbulence. The old stock market saying "never sell Shell" held true once again, with the shares deliverin

UK MORNING BRIEFING: WPP And Bunzl Please With Payouts

Glaxo's ViiV Healthcare Gets US Approval For HIV Treatment Triumeq

UPDATE 1-Canada's Immunovaccine Inc says test of Ebola vaccine promising

(New throughout, adds interview with CEO; adds byline) By Rod Nickel WINNIPEG, Manitoba, Aug 25 (Reuters) - Four monkeys survived the Ebola virus after being injected with a vaccine that included Immunovaccine Inc's technology, the tiny Canadian company said on Monday, and the announc

FTSE 100 movers: Miners slide as Astra gains on bid speculation

Mining stocks led the downside after metals consumer China disappointed with its manufacturing data and metal prices fell. Fresnillo, Randgold Resources, Anglo American, Rio Tinto and BHP Billiton all fell into the red. BHP was still under pressure in the aftermath of Tuesday's underwhelming plans

Sector movers: Astrazeneca boosts pharma stocks on Pfizer return hopes

Astrazenca was leading the pharmaceuticals sector higher on Thursday on the back of speculation that US drug giant Pfizer could return with a fresh offer in the coming days. The reports lifted others in the sector higher in afternoon trading with peers such as Glaxosmithkline, Hikma and BTG making

London close: Astrazeneca leads FTSE higher on bid speculation

- Healthcare stocks lift FTSE - German PMI data drives sentiment - Investors look ahead to Draghi speech - UK retail sales disappoint techMARK 2,819.77 +0.82% FTSE 100 6,777.66 +0.33% FTSE 250 15,838.57 +0.57% London's blue chips ended Thursday's session on a positive note, led by Astrazeneca. Inc

MARKET COMMENT: UK Gains Held Back By Miners

Pfizer back for AstraZeneca? Year-end move seen most likely

* AstraZeneca can invite Pfizer to talks from Aug. 26 * But UK drugmaker seen unlikely to make early move * Pfizer still looking at large acquisitions By Ben Hirschler LONDON, Aug 21 (Reuters) - Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, f

London midday: UK stocks advance as investors shrug off weak data

- Mining stocks fall as Chinese data weakens - Eurozone PMIs and UK retail sales disappoint - US data, Jackson Hole ahead techMARK 2,810.76 +0.50% FTSE 100 6,772.04 +0.25% FTSE 250 15,797.15 +0.31% Falls in the heavyweight mining sector weren't enough to stop the FTSE 100 from advancing on Thursda